Vera Therapeutics to Host In-Person R&D Day in New York to Present Week 72 Data from Phase ...

BRISBANE, Calif., Jan. 08, 2024 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA), a late clinical-stage biotechnology company developing and commercializing transformative treatments for patients with serious immunologic diseases, today

Related Keywords

Leicester ,United Kingdom ,Stanford ,Leicestershire ,Long Island Jewish Medical Center ,New York ,United States ,Brisbane ,Queensland ,Australia ,American ,America ,Jonathan Barratt ,Joyce Allaire ,Richard Lafayette ,Mari Purpura ,Stanford University Department Of Medicine ,Nephrology At Stanford University ,Communications Committee ,Stanford Glomerular Disease Center ,Renal Research Group ,Glomerular Disease Advisory Committee ,American Society Of Nephrology ,Lotte New York Palace Hotel ,Stanford University School Of Medicine ,American Society Of Nephrology Kidney Health Initiative ,Exchange Commission ,University Of Leicester ,Vera Therapeutics Inc ,College Of Life Sciences ,Stanford University Medical Center ,York Medical College ,Igan Rare Disease Group ,Nasdaq ,Drug Administration ,Castle Connolly Medical Ltd ,International Igan Network ,New York Palace Hotel ,Stanford University Medical ,New York Medical College ,Stanford University School ,Internal Medicine ,Associate Chair ,Stanford University Department ,Clinical Chief ,Stanford University ,Top Doctors ,Best Doctors ,Top Doctors Award ,Castle Connolly Medical ,Editorial Board ,Kidney News ,American Society ,Life Sciences ,Disease Group ,United Kingdom National Registry ,Rare Kidney Diseases ,Chief Investigator ,Nephrology Kidney Health Initiative ,Identifying Surrogate Endpoints ,Clinical Trials ,Private Securities Litigation Reform Act ,Region ,